SOUTH KOREA SAYS CONSIDERING ALL OPTIONS INCLUDING VACCINE EXPORT CURBS
South Korea is considering all options to secure enough coronavirus vaccine supplies, a top vaccine official said on Tuesday in response to questions about possible export curbs on locally made vaccines.
The remarks come as authorities face a backlash for relying on global vaccine-sharing scheme COVAX for a bulk of the country’s COVID-19 shots as shipment delays threaten to slow the inoculation programme.
Last week’s announcement that South Korea would only receive 432,000 doses instead of 690,000, and that delivery would be delayed to around the third week of April, is the second time that the country’s vaccine rollout has been hit by supply delays in the scheme.
When asked whether authorities were considering export curbs on AstraZeneca Plc shots produced by SK Chemicals Co Ltd unit SK bioscience, a COVID-19 vaccination management task force team lead told reporters all options were on the table.